![](/img/cover-not-exists.png)
An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation
Yu, Shengze, Alkharusi, Amira, Norstedt, Gunnar, Gräslund, Torbjörn, Henry, Kevin A.Volume:
14
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0215831
Date:
May, 2019
File:
PDF, 1.43 MB
english, 2019